Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Diego Sepulveda-Falla

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Brain Pathology (Zurich, Switzerland)|June 13, 2022
Evidence of beta amyloid independent small vessel disease in familial Alzheimer's diseaseJessica Lisa Littau, Lina Velilla, Yoshiki Hase, et al.
Acta Neuropathologica|December 11, 2012
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer diseaseMarta Pera, Daniel Alcolea, Raquel Sánchez-Valle, et al.
The Journal of Clinical Investigation|February 27, 2014
Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasisDiego Sepulveda-Falla, Alvaro Barrera-Ocampo, Christian Hagel, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Comorbidities in Early-Onset Sporadic versus Presenilin-1 Mutation-Associated Alzheimer's Disease Dementia: Evidence for Dependency on Alzheimer's Disease Neuropathological ChangesDiego Sepulveda-Falla, Carlos Andrés Villegas Lanau, Charles White, et al.
Brain Pathology (Zurich, Switzerland)|September 21, 2022
Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotectionJulián Henao-Restrepo, Carolina López-Murillo, Pablo Valderrama-Carmona, et al.
Journal of Neuropathology and Experimental Neurology|December 10, 2024
Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease neuropathological changesDiego Sepulveda-Falla, Carlos Andrés Villegas Lanau, Charles White Iii, et al.
Frontiers in Molecular Neuroscience|April 4, 2024
<i>APOE3</i> Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer's casesPaula Perez-Corredor, Timothy E Vanderleest, Guido N Vacano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Driving research on successful aging and neuroprotection in Latin America: Insights from the inaugural symposium on brain resilience and healthy longevityYakeel T Quiroz, David Aguillón, Joseph Arboleda-Velasquez, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's diseaseJay Rasmussen, Jasmin Mahler, Natalie Beschorner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumVincent Malotaux, David Fernando Aguillón Niño, Isabela Gonzalez, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Brain Pathology (Zurich, Switzerland)|June 13, 2022
Evidence of beta amyloid independent small vessel disease in familial Alzheimer's diseaseJessica Lisa Littau, Lina Velilla, Yoshiki Hase, et al.
Acta Neuropathologica|December 11, 2012
Distinct patterns of APP processing in the CNS in autosomal-dominant and sporadic Alzheimer diseaseMarta Pera, Daniel Alcolea, Raquel Sánchez-Valle, et al.
The Journal of Clinical Investigation|February 27, 2014
Familial Alzheimer's disease-associated presenilin-1 alters cerebellar activity and calcium homeostasisDiego Sepulveda-Falla, Alvaro Barrera-Ocampo, Christian Hagel, et al.
Medrxiv : the Preprint Server for Health Sciences|August 30, 2023
Comorbidities in Early-Onset Sporadic versus Presenilin-1 Mutation-Associated Alzheimer's Disease Dementia: Evidence for Dependency on Alzheimer's Disease Neuropathological ChangesDiego Sepulveda-Falla, Carlos Andrés Villegas Lanau, Charles White, et al.
Brain Pathology (Zurich, Switzerland)|September 21, 2022
Gliovascular alterations in sporadic and familial Alzheimer's disease: APOE3 Christchurch homozygote glioprotectionJulián Henao-Restrepo, Carolina López-Murillo, Pablo Valderrama-Carmona, et al.
Journal of Neuropathology and Experimental Neurology|December 10, 2024
Comorbidities in early-onset sporadic versus presenilin-1 mutation-associated Alzheimer disease dementia: Evidence for dependency on Alzheimer disease neuropathological changesDiego Sepulveda-Falla, Carlos Andrés Villegas Lanau, Charles White Iii, et al.
Frontiers in Molecular Neuroscience|April 4, 2024
<i>APOE3</i> Christchurch modulates β-catenin/Wnt signaling in iPS cell-derived cerebral organoids from Alzheimer's casesPaula Perez-Corredor, Timothy E Vanderleest, Guido N Vacano, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|March 27, 2025
Driving research on successful aging and neuroprotection in Latin America: Insights from the inaugural symposium on brain resilience and healthy longevityYakeel T Quiroz, David Aguillón, Joseph Arboleda-Velasquez, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 22, 2017
Amyloid polymorphisms constitute distinct clouds of conformational variants in different etiological subtypes of Alzheimer's diseaseJay Rasmussen, Jasmin Mahler, Natalie Beschorner, et al.
Alzheimer'S & Dementia : the Journal of the Alzheimer'S Association|December 23, 2025
Alzheimer's Imaging ConsortiumVincent Malotaux, David Fernando Aguillón Niño, Isabela Gonzalez, et al.
Pageof 6